Furthermore, in a cross-sectional study assessing SMN gene and protein expression in whole blood, there was no difference in SMN expression levels or any other gene expression changes correlating with disease severity between SMA and healthy cohorts (72). Here, SMN2 is linked to proximal spinal muscular atrophy.